The “real-world” efficacy and safety of DAAs for the treatment of HCV patients throughout Japan
Crossref DOI link: https://doi.org/10.1007/s00535-018-1493-8
Published Online: 2018-07-06
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Maekawa, Shinya http://orcid.org/0000-0002-5643-9472
Enomoto, Nobuyuki
Text and Data Mining valid from 2018-07-06
Article History
Received: 28 June 2018
Accepted: 3 July 2018
First Online: 6 July 2018